MedPath

Post-operative Oral Morphine Versus Ibuprofen

Phase 2
Completed
Conditions
Post-operative Pain
Interventions
Registration Number
NCT01686802
Lead Sponsor
Lawson Health Research Institute
Brief Summary

Children 5-17 years of age who have undergo orthopedic day surgical procedures for definitive management of fractures, tendon release, etc. will be randomized to receive either ibuprofen or oral morphine as needed for pain relief for 48 hours post-operatively at home. Pain will be assessed using the self-report Faces pain scale revised (FPS-R). We hypothesize that oral morphine will result in significantly lower pain scores on the Faces Pain Scale Revised (FPS-R) compared to ibuprofen. It is hoped that the results of this trial will create a new option for post-operative pain management in children.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
132
Inclusion Criteria
  • all children aged 5-17 years who undergo an elective orthopedic or fracture-related surgical procedure at the Children's Hospital in London, Ontario and have a same-day discharge.
Exclusion Criteria
  • known hypersensitivity to either ibuprofen or morphine
  • chronic users of NSAIDS or opioids
  • cognitive impairment
  • poor English fluency
  • pregnancy
  • acute or chronic renal insufficiency
  • bleeding disorder
  • obstructive sleep apnea

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ibuprofenIbuprofenibuprofen 10 mg/kg (max 600 mg) every 6 hours as needed for pain (maximum 8 doses) from the time the patient is discharged from hospital as deemed by the physician to a maximum of 48 hours.
oral morphineoral morphineoral morphine 0.5 mg/kg (max 20 mg) every 6 hours as needed for pain (maximum 8 doses) from the time the patient is discharged from hospital as deemed by the physician to a maximum of 48 hours.
Primary Outcome Measures
NameTimeMethod
Change in faces pain score pre and post intervention48 hours from the time of discharge from hospital.
Secondary Outcome Measures
NameTimeMethod
Change in faces pain score pre and post intervention48 hours from the time of discharge from hospital

Second to eighth doses of intervention

Number of participants requiring acetaminophen for breakthrough pain48 hours from first dose of intervention
Adverse effects96 hours from first dose of intervention
Unscheduled visits to a health care provider for pain96 hours from first dose of intervention

Trial Locations

Locations (1)

London Health Science Center

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath